PERSONAL STORIES DENTAL BONE GRAFTING
Find out how bone grafting surgeries can help people find relief. These personal stories can help you learn about what it’s like to have surgery using bone graft, but keep in mind that all treatment results are specific to the individual patient, and results may vary.
A video of Vivian, who shares her experience with receiving Infuse Bone Graft for a dental procedure.
Vivian began wearing dentures in her 30s due to bone loss. In her 60s, when the progressive bone loss meant her dentures no longer fit, Vivian's life was limited to eating soft foods and avoiding personal interactions. Infuse™ Bone Graft helped prepare her for dental implants so she could live life fully again. “Every month I’d go in and they’d X-Ray, and they could see the bone growing.”
Years after a car accident in her teenage years, severe jaw bone resorption left Edna with receding gums and tooth loss. Infuse Bone Graft helped rebuild Edna's jaw bone density in preparation for dental implants, restoring her confidence and "great big smile."
A video of Diane, who shares her experience with receiving Infuse Bone Graft for a dental procedure.
Diane's dental problems began with a baby tooth that never fell out and required one of her front teeth to be pulled. Then she began losing bone, resulting in the loss of more teeth. Infuse Bone Graft helped replace the missing bone and made her feel whole again. “I’m just thrilled. ... Nothing's loose, nothing hurts. I feel confident in my interactions with people.”
INFUSE® Bone Graft is indicated as an alternative to autogenous bone graft for sinus augmentations, and for localized alveolar ridge augmentations for defects associated with extraction sockets.
The INFUSE® Bone Graft consists of two components-recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) placed on an absorbable collagen sponge (ACS). These components must be used as a system for the prescribed indication. The bone morphogenetic protein solution component must not be used without the carrier/scaffold component or with a carrier/scaffold component different from the one described in the package insert.
INFUSE® Bone Graft is contraindicated for consumers with a known hypersensitivity to recombinant human Bone Morphogenetic Protein-2, bovine Type I collagen or to other components of the formulation and should not be used in the vicinity of a resected or extant tumor, in consumers with any active malignancy or consumers undergoing treatment for a malignancy, in pregnant women, or consumers with an active infection at the operative site.
There are no adequate and well-controlled studies in human pregnant women. In an experimental rabbit study, rhBMP-2 has been shown to elicit antibodies that are capable of crossing the placenta. Women of childbearing potential should be warned by their surgeon of potential risk to a fetus and informed of other possible dental treatments. The safety and effectiveness of this device has not been established in nursing mothers. Women of childbearing potential should be advised to not become pregnant for one year following treatment with this device.
INFUSE® Bone Graft has not been studied in consumers who are skeletally immature (<18 years of age or no radiographic evidence of epiphyseal closure).
Please see the package insert for the complete list of indications, warnings, precautions, adverse events, clinical results, and other important medical information.